tiprankstipranks
Asensus Surgical (ASXC)
NYSE MKT:ASXC

Asensus Surgical (ASXC) Technical Analysis

2,617 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Asensus Surgical’s (ASXC) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Asensus Surgical is a Buy.
Asensus Surgical’s (ASXC) 20-Day exponential moving average is 0.32, while Asensus Surgical’s (ASXC) share price is $0.336, making it a Buy.
Asensus Surgical’s (ASXC) 50-Day exponential moving average is 0.29, while Asensus Surgical’s (ASXC) share price is $0.336, making it a Buy.

Asensus Surgical (ASXC) Pivot Points

Jul 04, 2024, 09:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.32
0.32
0.33
0.33
0.33
0.34
0.34
Fibonacci
0.32
0.33
0.33
0.33
0.33
0.34
0.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Asensus Surgical (ASXC) Moving Averages

Jul 04, 2024, 09:26 AM
Period
Simple
Exponential
MA5
0.33Buy
0.33Buy
MA10
0.33Buy
0.33Buy
MA20
0.32Buy
0.32Buy
MA50
0.28Buy
0.29Buy
MA100
0.28Buy
0.28Buy
MA200
0.27Buy
0.29Buy
Asensus Surgical’s (ASXC) 10-Day exponential moving average is 0.33, while Asensus Surgical’s (ASXC) share price is $0.336, making it a Buy.
Asensus Surgical’s (ASXC) 100-Day exponential moving average is 0.28, while Asensus Surgical’s (ASXC) share price is $0.336, making it a Buy.
Asensus Surgical’s (ASXC) stock price is $0.336 and Asensus Surgical’s (ASXC) 50-day simple moving average is 0.28, creating a Buy signal.
Asensus Surgical’s (ASXC) stock price is $0.336 and Asensus Surgical’s (ASXC) 100-day simple moving average is 0.28, creating a Buy signal.
Asensus Surgical’s (ASXC) stock price is $0.336 and Asensus Surgical’s (ASXC) 200-day simple moving average is 0.27, creating a Buy signal.

Asensus Surgical (ASXC) Technical Indicators

Jul 04, 2024, 09:26 AM
Name
Value
Implied Action
RSI (14)
66.96
Neutral
STOCH (9,6)
111.11
Sell
STOCHRSI (14)
111.11
Sell
MACD (12,26)
0.02
Buy
ADX (14)
34.30
Neutral
Williams %R
33.33
Sell
CCI (14)
57.22
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
72.72
Buy
ROC
3.03
Buy
Asensus Surgical’s (ASXC) Relative Strength Index (RSI) is 66.96, creating a Neutral signal.
Asensus Surgical’s (ASXC) Trend Strength Indicator (ADX) is 34.30, creating a Neutral signal.
Asensus Surgical’s (ASXC) Commodity Channel Index (CCI) is 57.22, creating a Neutral signal.
Asensus Surgical’s (ASXC) Price Rate of Change (ROC) is 3.03, creating a Buy signal.

FAQ

Is ASXC a Buy, Hold, or Sell?
Based on ASXC’s technical indicators, ASXC is a Strong Buy.
    What is ASXC’s RSI (14)?
    ASXC’s RSI (14) is 66.96, which suggests ASXC is a Neutral.
      What is ASXC’s MACD?
      ASXC’s MACD is 0.02, which suggests ASXC is a Buy.
        What is ASXC’s 5-day moving average?
        ASXC’s 5-day moving average is 0.33, which suggests ASXC is a Buy.
          What is ASXC’s 20-day moving average?
          ASXC 20-day moving average is 0.32, which suggests ASXC is a Buy.
            What is ASXC’s 50-day moving average?
            ASXC’s 50-day moving average is 0.28, which suggests ASXC is a Buy.
              What is ASXC’s 200-day moving average?
              ASXC’s 200-day moving average is 0.27, which suggests ASXC is a Buy.
                What is ASXC’s Williams % R (14)?
                ASXC’s Williams % R (14) is 33.33, which suggests ASXC is a Sell.
                  What is ASXC’s CCI (14)?
                  ASXC’s CCI (14) is 57.22, which suggests ASXC is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis